NLR and PLR as novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF
[ X ]
Tarih
2020
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Oxford University Press
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
To the Editors, We read with curiosity the recently published article titled “Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF: Neutrophil to Lymphocyte Ratio and Platelet-toLymphocyte Ratio” by Bertani et al.1 In the article, authors aimed to assess whether neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) could be used as prognostic markers of antitumor necrosis factor (anti-TNF) treatment response in patients with ulcerative colitis.
Açıklama
Anahtar Kelimeler
Kaynak
Inflammatory Bowel Diseases
WoS Q Değeri
N/A
Scopus Q Değeri
Q1
Cilt
26
Sayı
9
Künye
Düzenli, T., Köseoğlu, H., & Akyol, T. (2020). NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF. Inflammatory Bowel Diseases, 26(9), e103-e103.
